{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:02:31Z","timestamp":1791093751036,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ejso.2013.06.022","type":"journal-article","created":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T08:30:24Z","timestamp":1374049824000},"page":"1109-1115","source":"Crossref","is-referenced-by-count":39,"title":["Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial ovarian carcinoma: Upfront therapy, at first recurrence, or later?"],"prefix":"10.1016","volume":"39","author":[{"given":"L.","family":"Gonzalez Bayon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Vasquez Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Asencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Alvarez de Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Atahualpa Arenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rodriguez del Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Garcia Sabrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2013.06.022_bib1","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a metaanalysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2013.06.022_bib2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?","volume":"103","author":"Chi","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib3","series-title":"Advances in peritoneal surface oncology","first-page":"11","article-title":"The natural history of free cancer cells in the peritoneal cavity","author":"Yonemura","year":"2007"},{"key":"10.1016\/j.ejso.2013.06.022_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced EOC as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib5","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2013.06.022_bib6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"Markman","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ejso.2013.06.022_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2005.11.013","article-title":"Intraperitoneal catheter outcomes in a phase III trail of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study","volume":"100","author":"Walker","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2013.06.022_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?","volume":"7","author":"Sugarbaker","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib10","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study","volume":"28","author":"Elias","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2013.06.022_bib12","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00432-009-0667-4","article-title":"Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results","volume":"135","author":"Chua","year":"2009","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jso.21068","article-title":"The intraoperative staging system in the management of peritoneal surface malignancy","volume":"98","author":"Portilla","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2013.06.022_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jso.21072","article-title":"Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy","volume":"98","author":"Gonz\u00e1lez-Moreno","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib16","series-title":"Technical handbook for the integration of cytoreductive surgery and perioperative intraperitoneal chemotherapy into the surgical management of gastrointestinal and gynecologic malignancy","first-page":"52","author":"Sugarbaker","year":"2005"},{"key":"10.1016\/j.ejso.2013.06.022_bib17","series-title":"Common terminology criteria for adverse events","author":"Cancer Therapy Evaluation Program","year":"2003"},{"key":"10.1016\/j.ejso.2013.06.022_bib18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1055-3207(03)00029-2","article-title":"Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents","volume":"12","author":"Sticca","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.ejso.2013.06.022_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ygyno.2006.08.037","article-title":"Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome","volume":"104","author":"Karam","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2013.06.022_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/bjc.1994.45","article-title":"Response of peritoneal solid tumors after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin","volume":"69","author":"Los","year":"1994","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2013.06.022_bib21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00280-008-0800-0","article-title":"A\u00a0pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin","volume":"63","author":"Van der Speeten","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.ejso.2013.06.022_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/IGC.0b013e31819bdc7e","article-title":"Survival after second-line intraperitoneal therapy for the treatment of epithelial ovarian cancer: the Gynecologic Oncology Group experience","volume":"19","author":"Markman","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2013.06.022_bib23","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","article-title":"Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality","volume":"249","author":"Chua","year":"2009","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2013.06.022_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1245\/s10434-006-9167-9","article-title":"Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis","volume":"14","author":"Elias","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib25","article-title":"HIPEC\u00a0+\u00a0EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy","author":"McConnell","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2013.06.022_bib27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study","volume":"90","author":"Eisenkop","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2013.06.022_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/IGC.0b013e3181c50cde","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry","volume":"20","author":"Helm","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2013.06.022_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2011.05.004","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial","volume":"122","author":"Deraco","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib31","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1245\/s10434-006-9273-8","article-title":"Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer","volume":"14","author":"Benedetti Panici","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncr.22447","article-title":"Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome","volume":"109","author":"Salani","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2013.06.022_bib33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/annonc\/mdn591","article-title":"The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer","volume":"20","author":"Oksefjell","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jso.21491","article-title":"Surgery in recurrent epithelial ovarian cancer: benefits on Survival for patients with residual disease of 0.1\u20131\u00a0cm after secondary cytoreduction","volume":"101","author":"Tian","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2013.06.022_bib35","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1245\/s10434-012-2510-4","article-title":"Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 patients","volume":"19","author":"Bakrin","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.06.022_bib36","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ygyno.2010.01.046","article-title":"Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series","volume":"117","author":"Shih","year":"2010","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798313004605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798313004605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:47:57Z","timestamp":1596156477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798313004605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0748798313004605"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2013.06.022","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}